Between 40 and 70 percent of patients on these drugs report gastrointestinal adverse effects, like acid reflux, chronic diarrhea, and/or constipation
Pavlova and Thompson, 2016
The mean absolute bioavailability of Tirzepatide following subcutaneous administration is 80% (source)
Clinical Pharmacology.] Use with Medications Known to Cause Hypoglycemia As is typical with other antihyperglycemic agents used in combination with a sulfonylurea, when Januvia was used in combination with a sulfonylurea, a class of medications known to cause hypoglycemia, the incidence of hypoglycemia was increased over that of placebo
Mass spectra were acquired on an ultraflex III MALDI-TOF/TOF mass spectrometer (Bruker Daltonics) operating in reflective positive mode
They are not held to the same manufacturing standards, and their dose accuracy can vary